These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20530022)

  • 21. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease.
    Rutter MK; Nesto RW
    Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Has anything changed in multivessel coronary artery revascularization in diabetes since BARI?
    Kapur A; Bartolini D; Beatt KJ
    Ital Heart J; 2004 May; 5(5):358-63. PubMed ID: 15185899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coronary revascularization in the diabetic].
    Steg PG; Karila-Cohen D
    Diabetes Metab; 1999 Jun; 25 Suppl 3():53-7. PubMed ID: 10421994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.
    Kapur A; Malik IS; Bagger JP; Anderson JR; Kooner JS; Thomas M; Punjabi P; Mayet J; Millane T; Goedicke J; Jamrozik K; de Belder MA; Hall RJ; Beatt KJ
    Am Heart J; 2005 Jan; 149(1):13-9. PubMed ID: 15660030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized clinical trials: do they really make a difference? BARI and diabetes mellitus.
    Holmes DR
    Cathet Cardiovasc Diagn; 1996 Mar; 37(3):351-2. PubMed ID: 8974825
    [No Abstract]   [Full Text] [Related]  

  • 28. Coronary revascularisation in the patient with diabetes: balancing risk and benefit.
    Rutter MK; Nesto RW
    Heart; 2010 Sep; 96(18):1436-40. PubMed ID: 20813726
    [No Abstract]   [Full Text] [Related]  

  • 29. Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
    Berger PB; Sketch MH; Califf RM
    Circulation; 2004 Mar; 109(9):1079-81. PubMed ID: 15007018
    [No Abstract]   [Full Text] [Related]  

  • 30. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial.
    Farkouh ME; Dangas G; Leon MB; Smith C; Nesto R; Buse JB; Cohen DJ; Mahoney E; Sleeper L; King S; Domanski M; McKinlay S; Fuster V
    Am Heart J; 2008 Feb; 155(2):215-23. PubMed ID: 18215589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coronary angioplasty compared with aortocoronary bypass in patients with multivascular coronary disease].
    Morocutti G; Vendrametto F; Werren M; Spedicato L; Bernardi G; Gregori D; Fioretti PM
    Ital Heart J Suppl; 2000 Jun; 1(6):759-65. PubMed ID: 11204007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of revascularization on mortality in patients with nonacute coronary artery disease.
    Jeremias A; Kaul S; Rosengart TK; Gruberg L; Brown DL
    Am J Med; 2009 Feb; 122(2):152-61. PubMed ID: 19185092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
    Bach RG; Brooks MM; Lombardero M; Genuth S; Donner TW; Garber A; Kennedy L; Monrad ES; Pop-Busui R; Kelsey SF; Frye RL;
    Circulation; 2014 Apr; 129(16):e460-1. PubMed ID: 24753557
    [No Abstract]   [Full Text] [Related]  

  • 35. Revascularization for ischaemic cardiomyopathy.
    Shanmugam G; Légaré JF
    Curr Opin Cardiol; 2008 Mar; 23(2):148-52. PubMed ID: 18303528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Coronary artery surgery in patients with diabetes mellitus].
    Lauruschkat AH; Ennker J
    Dtsch Med Wochenschr; 2002 Feb; 127(8):381-3. PubMed ID: 11859447
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular disease in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
    Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial).
    Holper EM; Brooks MM; Kim LJ; Detre KM; Faxon DP;
    Am J Cardiol; 2007 Jul; 100(2):196-202. PubMed ID: 17631069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial.
    Bittner V; Bertolet M; Barraza Felix R; Farkouh ME; Goldberg S; Ramanathan KB; Redmon JB; Sperling L; Rutter MK;
    J Am Coll Cardiol; 2015 Aug; 66(7):765-773. PubMed ID: 26271057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.